novo nordisk glp 1 pill How Nordisk's weight loss is drawing in new patients for obesity treatment Novo Nordisk's Wegovy Pill Becomes

The most frequently reported side effects of Wegovy are gastrointestinal in nature, including nausea (very common, 1/10), vomiting, diarrhoea, constipation, and abdominal pain

As GLP-1 therapies expand beyond diabetes and obesity, understanding their anti-inflammatory mechanisms may unlock new therapeutic uses

doi: 10.1136/bmj.c2181

For example, one study showed that consuming white tea led to a significant decrease in body weight, waist circumference, and BMI parameters among a group of study participants who also followed a diet and exercise program

Effect of oral semaglutide on energy intake, appetite, control of eating and gastric emptying in adults living with obesity: a randomized controlled trial

For most women, the clinical conversation ends at oral contraceptives for cycle regulation, metformin for insulin resistance, and the diffuse instruction to "lose weight." What it rarely includes is any serious engagement with the signaling dysfunctions that make PCOS resistant to those blunt interventions in the first place